Biblio Discovery — Demo Discovery Service

10 results for "2"

Showing 1–10 · 0.36 seconds · RSS

  1. Journal Article

    Reproducibility and sensitivity of 36 methods to quantify the SARS-CoV-2 genetic signal in raw wastewater: findings from an interlaboratory methods evaluation in the U.S.

    Brian M. Pecson; Emily Darby; Charles Nathan Haas et al.

    Environmental Science Water Research & Technology · 2021 · English · OpenAlex Scopus

    range of recovery efficiency and limit of detection highlighting the importance of recovery correction and the need to consider method sensitivity when selecting methods for wastewater surveillance.

  2. Journal Article Full text

    Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

    Andreas Wollenberg; Andrew Blauvelt; Emma Guttman‐Yassky et al.

    British Journal of Dermatology · 2020 · English · OpenAlex Scopus

    BACKGROUND: Tralokinumab, a fully human monoclonal antibody, specifically neutralizes interleukin-13, a key cytokine driving peripheral inflammation in atopic dermatitis (AD). In phase II studies, tralokinumab combined with topical corticosteroids provided early and sustained improvements in AD…

  3. Journal Article

    Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

    Hirotoshi Watanabe; Takeshi Morimoto; Masahiro Natsuaki et al.

    JAMA Cardiology · 2022 · English · OpenAlex Scopus

    IMPORTANCE: Clopidogrel monotherapy after short dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has not yet been fully investigated in patients with acute coronary syndrome (ACS). OBJECTIVE: To test the hypothesis of noninferiority of 1 to 2 months of DAPT compared…

  4. Journal Article Full text

    Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation

    David Julian Seiffge; Gian Marco De Marchis; Masatoshi Koga et al.

    Annals of Neurology · 2020 · English · OpenAlex Scopus

    Objective It is not known whether patients with atrial fibrillation (AF) with ischemic stroke despite oral anticoagulant therapy are at increased risk for further recurrent strokes or how ongoing secondary prevention should be managed. Methods We conducted an individual patient data pooled analysis…

  5. Journal Article Full text

    Donanemab in Early Symptomatic Alzheimer Disease

    John Randall Sims; Jennifer A. Zimmer; Cynthia Duggan Evans et al.

    JAMA · 2023 · English · OpenAlex

    Importance: There are limited efficacious treatments for Alzheimer disease. Objective: To assess efficacy and adverse events of donanemab, an antibody designed to clear brain amyloid plaque. Design, Setting, and Participants: Multicenter (277 medical research centers/hospitals in 8 countries)…

  6. Journal Article Full text

    Global disparities in SARS-CoV-2 genomic surveillance

    Anderson Fernandes Brito; Elizaveta Petrovna Semеnova; Gytis Dudas et al.

    Nature Communications · 2022 · English · OpenAlex Scopus

    Genomic sequencing is essential to track the evolution and spread of SARS-CoV-2, optimize molecular tests, treatments, vaccines, and guide public health responses. To investigate the global SARS-CoV-2 genomic surveillance, we used sequences shared via GISAID to estimate the impact of sequencing…

  7. Journal Article Full text

    Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia

    The COVID STEROID 2 Trial Group; Lene Russell; Kis Rønn Uhre et al.

    JAMA · 2021 · English · OpenAlex

    Importance: A daily dose with 6 mg of dexamethasone is recommended for up to 10 days in patients with severe and critical COVID-19, but a higher dose may benefit those with more severe disease. Objective: To assess the effects of 12 mg/d vs 6 mg/d of dexamethasone in patients with COVID-19 and…